Table 4: Changes in lipid metabolism markers by alogliptin between patients with BMI < 25 kg/m2 and BMI > 25 kg/m2 . Data are means ± SD. * p < 0.05 between BMI < 25 kg/m2 and BMI > 25kg/m2

n Baseline 8 weeks Absolute change from baseline Percent change from baseline (%)
LDL (mg/dl) BMI< 25 25 103.1 ± 17.0 96.0 ± 21.1 -7.16 ± 13.8 -6.93 ± 14.3
BMI>25 20 102.7 ± 23.2 100.4 ± 21.1 -2.30 ± 9.10 -2.14 ± 8.49
HDL (mg/dl) BMI< 25 25 65.5 ± 20.7 64.6 ± 19.9 -0.88 ± 6.46 -0.46 ± 10.4
BMI>25 20 54.7 ± 16.0 58.3 ± 15.9 3.60 ± 4.78 7.24 ± 9.07
TG (mg/dl) BMI< 25 25 135.9 ± 94.0 117.6 ± 81.1 -18.4 ± 55.4 -8.90 ± 32.3
BMI>25 20 139.2 ± 96.2 114.1 ± 58.3 -25.1 ± 79.3 -7.75 ± 30.6
Apo B (mg/dl) BMI< 25 11 93.6 ± 11.6 87.6 ± 12.9 -6.09 ± 9.51 -6.35 ± 9.34
BMI>25 10 88.1 ± 20.7 82.2 ± 15.2 -5.9 ± 8.92 -5.43 ± 8.49
Apo B/A-1 (mg/dl) BMI< 25 11 156.6 ± 33.8 151.8 ± 33.9 -4.73 ± 11.0 -3.03 ± 6.36
BMI>25 10 149.4 ± 19.3 156.2 ± 21.5 6.80 ± 10.1 4.70 ± 6.97
Apo B/A-1 BMI< 25 11 0.621 ± 0.133 0.595 ± 0.114 -0.026 ± 0.05 -3.27 ± 8.98
BMI>25 10 0.600 ± 0.179 0.537 ± 0.135 -0.064 ± 0.061 -9.54 ± 8.03
LDL /Apo B BMI< 25 11 1.14 ± 0.13 1.19 ± 0.17 0.048 ± 0.069 4.79 ± 6.94
BMI>25 10 1.18 ± 0.086 1.21 ± 0.092 0.094 ± 0.20 3.02 ± 5.29